Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
JAZZ logo

JAZZ

NGS
Jazz Pharmaceuticals plc
HealthcareBiotechnology
Watchlists:
Last updated: Monday 14th July 2025
110.27
-2.21 (-1.96%)
Prev Close:112.48
Open:111.97
Bid:109.5
Ask:118.1
52 Week Range
95.49
148.06
Volume:948,331
Mkt Cap:6,726 M
Price Target
$126.81
+15.0%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Moving Averages
Volatility Metrics
Financials

Financial Statements

JAZZ - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Acquired In Process Rn D Income-638000.0
Depreciation And Amortization627 M608 M599 M526 M260 M355 M201 M152 M102 M98 M
Development Expense10 M19 M444 M251 M110 M85 M24 M
Earnings From Equity Interest-2 M-3 M-10 M-714000.0-3 M-4 M-4 M-1 M-379000.0
Earnings From Equity Interest Net Of Tax-2 M-3 M-10 M-714000.0-3 M-4 M-4 M-1 M-379000.0
Gain On Sale Of Business-1 M100000.0-638000.0
Gain On Sale Of PPE-21000.0-655000.0-473000.0
Gain On Sale Of Security-17 M
General And Administrative Expense1,385 M1,343 M1,417 M1,452 M854 M737 M-12 M-15 M-12 M-10 M
Gross Profit Margin (profit Margin After CGS)3,623 M3,834 M3,119 M2,653 M2,215 M2,290 M1,769 M1,619 M1,488 M1,325 M
Impairment Of Capital Assets134 M136 M43 M32 M
Interest Expense Non Operating442000.0377000.0288 M279 M100 M59 M-57 M-38 M-27 M
Minority Interests1000.0
Misc Other Special Charges2 M3 M5 M5 M7 M1 M
Net Income (loss)560 M415 M-224 M-330 M239 M523 M447 M488 M397 M330 M
Net Income Common Stockholders560 M415 M-224 M-330 M239 M779 M447 M488 M397 M330 M
Net Income Continuous Operations560 M415 M-224 M-330 M239 M523 M447 M488 M397 M330 M
Net Non Operating Interest Income Expense-238 M-289 M-288 M-279 M-100 M-72 M-77 M-78 M-62 M-57 M
Normalized Income379 M
Operating Income717 M579 M-66 M170 M378 M532 M658 M529 M592 M540 M
Operating Income Before Depreciation (EBITDA)1,129 M934 M535 M718 M653 M930 M733 M598 M641 M567 M
Operating Expense2,907 M2,820 M2,607 M2,483 M1,700 M1,501 M1,112 M-1,090 M-896 M-817 M
Other Gand A1,385 M1,343 M1,417 M1,452 M854 M737 M-12 M-15 M-12 M-10 M
Other Operating Expenses-33 M-15 M-25 M-27 M-28 M-28 M-23 M110 M105 M103 M
Promotion And Advertising107 M92 M109 M162 M100 M65 M-37 M-37 M-29 M-28 M
Rent And Landing Fees-12 M-15 M-12 M-10 M
Research Expense884 M850 M590 M506 M335 M300 M227 M198 M162 M135 M
Restructring And Mn A Income-2 M
Salaries And Wages-41 M-40 M-41 M-34 M-13 M-16 M-102 M-107 M-99 M-92 M
Selling And Marketing Expense107 M92 M109 M162 M100 M65 M684 M544 M503 M449 M
Selling Expense684 M544 M503 M449 M
Total Income Available For Interest Expense (EBIT)469 M295 M-94 M166 M375 M513 M473 M403 M505 M436 M
Total Revenues4,069 M3,834 M3,659 M3,094 M2,364 M2,162 M1,891 M1,619 M1,488 M1,325 M
Total Expenses2,907 M2,820 M3,147 M2,042 M1,552 M1,374 M1,233 M-1,090 M-896 M-817 M
Total Revenue4,069 M3,834 M3,659 M3,094 M2,364 M2,162 M1,891 M1,619 M1,477 M1,317 M
Write Down-13 M
Amord627 M608 M599 M526 M260 M355 M201 M152 M102 M98 M
Avgshs62 M63 M63 M60 M56 M57 M60 M60 M61 M61 M
Avgshsdt66 M72 M63 M60 M57 M58 M61 M61 M62 M63 M
Basiceps9.066.55-3.58-5.524.289.227.458.136.565.38
Basicepscont9.066.55-3.58-5.524.289.22
Cor446 M436 M541 M-441 M-149 M-128 M122 M
Depamor33 M30 M30 M27 M19 M15 M-15 M-13 M-12 M98 M
Dileps8.656.1-3.58-5.524.229.097.37.966.415.23
Dilepscont8.656.1-3.58-5.524.229.09
Intinc-238 M-289 M-288 M-279 M-100 M-72 M-77 M-78 M-62 M-57 M
Netincdisc560 M415 M-224 M-330 M239 M523 M447 M488 M397 M330 M
Othincexp2 M3 M-597 M714000.03 M4 M4 M1 M1 M17 M
Pretaxinc470 M298 M-373 M-113 M275 M454 M529 M441 M532 M436 M
Resdev894 M869 M1,035 M506 M587 M410 M227 M283 M186 M135 M
Restruct-2 M
Sga1,385 M1,343 M1,417 M1,452 M854 M737 M684 M544 M503 M449 M
Shsout61 M62 M63 M62 M56 M56 M57 M60 M60 M61 M
Specincchg-134 M-136 M-43 M-32 M
Taxprov-91 M-120 M-159 M216 M34 M-73 M80 M-48 M135 M106 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader